Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results
Last xenon pharmaceuticals, inc earnings: 11/5 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com
BURNABY, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its 2020 financial and operating results after the close of U.S. financial markets on Monday, March 1, 2021: Xenon management will host a conference call and live audio webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) on Monday, March 1, 2021 to discuss the year-end results and to provide a corporate update. The webcast will be broadcast live on the Investors section of the Xenon website. To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, and provide conference ID number 6061326. In addition, Xenon will participate in a fireside discussion at the following upcoming virtual investor conference, which will be webcast live on the Investors section of the Xenon website: SVB Leerink 10th Annual Global Healthcare Conference at 10:00 am Eastern Time on Wedn
[Read more]
| Impact snapshot | Event time: | XENE | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
XENE alerts
XENE alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XENE alerts
High impacting Xenon Pharmaceuticals, Inc news events
Weekly update
A roundup of the hottest topics
XENE
News
- B.C. startup Eupraxia attempting rare TSX-only biotech IPO, raising hopes for revival of issues on senior Canadian exchange [Toronto Globe and Mail (Ontario, Canada)]Toronto Globe and Mail
- B.C. startup attempting rare TSX-only biotech IPO, raising hopes for revival of issues on senior Canadian exchange [Toronto Globe and Mail (Ontario, Canada)]Toronto Globe and Mail
- Xenon Pharmaceuticals Announces Promising New Pre-Clinical Data and Provides Clinical Overview of its XEN1101 Program at ASENT 2021GlobeNewswire
- Xenon Pharmaceuticals Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/XENE/price-target/">NASDAQ: XENE</a>) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.MarketBeat
- Xenon Pharmaceuticals Outlines Key Milestone Opportunities and Planned Leadership Transition in 2021GlobeNewswire
- More
XENE
SEC Filings
- 2/18/21 - Form 4
- 2/16/21 - Form SC
- 2/12/21 - Form SC
- XENE's page on the SEC website
- More